CtDNA useful biomarker for muscle-invasive bladder cancer patients who received perioperative durvalumab

Neoadjuvant PD-1 blockade enables organ preservation in early dMMR tumours without surgery

WRN inhibitor shows promise in patients with MSI and/or dMMR advanced solid tumours

Olaparib plus pembrolizumab shows promising results in BRCA mutated cancers

Exploring colorectal cancer in Hispanic/Latino populations through multi-omics analysis of MYC gene and WNT signalling pathway alteration

Metastasis-directed radiotherapy shows good prognosis for oligometastatic kidney cancer

Circulating tumour DNA can guide adjuvant immunotherapy for mismatch repair-deficient tumours

EGFR shows to be a promising therapeutic target in NF1 mutant melanoma

ELCC 2025: Latest in EGFR positive NSCLC

Digital pathology superior to manual SP263 PD-L1 TC scoring for stage II-IIIA high PD-L1 expression NSCLC

The added value of integrative medicine

TAR-200 plus cetrelimab show encouraging outcomes for MIBC patients ineligible for standard cisplatin-based chemotherapy